ReviewOphthalmology and therapy2025
The Rising Importance of Antiseptics in Ophthalmology: From Endophthalmitis Prevention to Treatment of Ocular Infections.
Review in Ophthalmology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Real-World Management and Patterns of Antibiotic Use in Patients with Keratitis and Ocular Surface Injuries: A Nationwide Survey Study in Spain.Antibiotics (Basel, Switzerland) · 2026Article
- In Vitro Bactericidal Activity of Propamidine 0.1% and Other Ophthalmic Antiseptics on Conjunctivitis and Blepharitis Strains.Ophthalmology and therapy · 2026Article
- Intraocular Lens Modifications for Postoperative Complication Prevention: Advances in Surface Engineering, Drug Delivery, and Photo-Responsive Strategies.Pharmaceutics · 2026Review
- Reduction in Ocular Surface Culture Positivity Following Short-Term Treatment with Liposomal Ozonated Oil Eyedrops.Clinics and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative endophthalmitis (POE) is a rare but severe intraocular infection that can lead to irreversible vision loss if not promptly and adequately treated. This condition occurs when infecting organisms enter the eye through direct inoculation, such as during intraocular surgery, penetrating trauma, or contiguous spread from adjacent tissues. The risk of infection has also increased with the growing use of intravitreal pharmacotherapy, such as treatments with antivascular endothelial growth factor agents. Sources of infection in POE include bacteria colonized on the patient's eyelid margin and conjunctiva, healthcare personnel, surgical instruments, solutions, and intraocular lenses. Microbial trends indicate that Staphylococcus epidermidis (S. epidermidis) and unspecified coagulase-negative Staphylococci (CoNS) are the most prevalent pathogens. Fungal endophthalmitis, commonly caused by Candida albicans, primarily affects patients who are immunocompromised, including those with human immunodeficiency virus (HIV), malignancies, diabetes mellitus, immunosuppressive medication or intravenous drug use, solid organ transplantation, lung disease, and renal insufficiency. The management of POE relies on the prompt initiation of appropriate empirical antibiotic therapy targeting the most common causative organisms. However, antimicrobial resistance (AMR) has become one of the most pressing global health challenges, with the World Health Organization (WHO) recognizing AMR as one of the top ten global public health threats. The goal is to ensure the judicious use of antibiotics while preventing AMR development. A critical preventive strategy in ophthalmology is the use of antiseptics before interventional eye procedures. Studies have shown that the application of effective antiseptic agents-such as povidone-iodine (PVP-I), chlorhexidine (CHX), hypochlorous acid (HOCl), polyhexamethylene biguanide (PHMB), and picloxydine dihydrochloride can significantly reduce the incidence of postoperative infections, thereby minimizing the risk of endophthalmitis. This article reviews the importance, effectiveness, and benefits of preoperative antiseptic use in ophthalmology, emphasizing their role in preventing infections without encouraging antibiotic resistance. In addition to their preventive role, it also examines the potential therapeutic applications of these same agents in the management of ocular infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.